These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34769797)

  • 21. [Acupuncture Treatment of Polycystic Ovarian Syndrome Patients with Abdominal Obesity by Regulating Dai Meridian: A Randomized Controlled Clinical Trial].
    Shen LY; Liang CM; Yang WJ; Pan L; Li H; Hu H
    Zhen Ci Yan Jiu; 2018 Apr; 43(4):255-9. PubMed ID: 29888581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgen levels and metabolic parameters are associated with a genetic variant of F13A1 in women with polycystic ovary syndrome.
    Schweighofer N; Lerchbaum E; Trummer O; Schwetz V; Pilz S; Pieber TR; Obermayer-Pietsch B
    Gene; 2012 Aug; 504(1):133-9. PubMed ID: 22565190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J; Bergh T; Berne C; Lithell H
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.
    Ezeh U; Pall M; Mathur R; Azziz R
    Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomere Length and Telomerase Activity in Immature Oocytes and Cumulus Cells of Women with Polycystic Ovary Syndrome.
    Pedroso DCC; Santana VP; Donaires FS; Picinato MC; Giorgenon RC; Santana BA; Pimentel RN; Keefe DL; Calado RT; Ferriani RA; Furtado CLM; Reis RM
    Reprod Sci; 2020 Jun; 27(6):1293-1303. PubMed ID: 32046456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The connection of alpha-1 acid glycoprotein inflammatory marker with anthropometric, hormonal, and metabolic characteristic of women with polycystic ovary syndrome.
    de Medeiros SF; de Medeiros MAS; Barbosa BB; Yamamoto AKLW; Yamamoto MMW
    J Obstet Gynaecol Res; 2021 Oct; 47(10):3571-3582. PubMed ID: 34265865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aerobic physical training impact on adipokines in women with polycystic ovary syndrome - Effects of body fat percentage.
    de Souza HCD; Philbois SV; de Paula Facioli T; Ferriani RA; Gastaldi AC
    Arch Endocrinol Metab; 2022 Nov; 66(6):837-847. PubMed ID: 35929900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A three-component cognitive behavioural lifestyle program for preconceptional weight-loss in women with polycystic ovary syndrome (PCOS): a protocol for a randomized controlled trial.
    Jiskoot G; Benneheij SH; Beerthuizen A; de Niet JE; de Klerk C; Timman R; Busschbach JJ; Laven JS
    Reprod Health; 2017 Mar; 14(1):34. PubMed ID: 28264692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
    Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J
    Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring factors related to changes in body composition, insulin sensitivity and aerobic capacity in response to a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome.
    Scott D; Harrison CL; Hutchison S; de Courten B; Stepto NK
    PLoS One; 2017; 12(8):e0182412. PubMed ID: 28771628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obesity may be the common pathway for sleep-disordered breathing in women with polycystic ovary syndrome.
    Suri J; Suri JC; Chatterjee B; Mittal P; Adhikari T
    Sleep Med; 2016 Aug; 24():32-39. PubMed ID: 27810183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory biomarkers and telomere length in women with polycystic ovary syndrome.
    Pedroso DC; Miranda-Furtado CL; Kogure GS; Meola J; Okuka M; Silva C; Calado RT; Ferriani RA; Keefe DL; dos Reis RM
    Fertil Steril; 2015 Feb; 103(2):542-7.e2. PubMed ID: 25467041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supervised exercise training and increased physical activity to reduce cardiovascular disease risk in women with polycystic ovary syndrome: study protocol for a randomized controlled feasibility trial.
    Woodward A; Broom D; Dalton C; Metwally M; Klonizakis M
    Trials; 2020 Jan; 21(1):101. PubMed ID: 31959233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome.
    Fulghesu A; Magnini R; Portoghese E; Angioni S; Minerba L; Melis GB
    J Adolesc Health; 2010 May; 46(5):474-81. PubMed ID: 20413084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Androgen Levels, Endocrine and Metabolic Indices, and Clinical Findings in Women with Polycystic Ovary Syndrome in Uygur and Han Ethnic Groups from Xinjiang Province in China.
    Zhao H; Song X; Zhang L; Xu Y; Wang X
    Med Sci Monit; 2018 Sep; 24():6774-6780. PubMed ID: 30252834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison between rimonabant and metformin in reducing biochemical hyperandrogenaemia and insulin resistance in patients with polycystic ovary syndrome (PCOS): a randomized open-label parallel study.
    Sathyapalan T; Cho LW; Kilpatrick ES; Coady AM; Atkin SL
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):931-5. PubMed ID: 18410553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dyslipidaemia in polycystic ovarian syndrome: different groups, different aetiologies?
    Meirow D; Raz I; Yossepowitch O; Brzezinski A; Rosler A; Schenker JG; Berry EM
    Hum Reprod; 1996 Sep; 11(9):1848-53. PubMed ID: 8921052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Visceral Adiposity Index as Predictor of Metabolic Syndrome in Obese and Nonobese Women with Polycystic Ovary Syndrome.
    de Medeiros SF; de Medeiros MAS; Barbosa BB; Yamamoto MMW
    Metab Syndr Relat Disord; 2021 Feb; 19(1):18-25. PubMed ID: 32845813
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular, anthropometric, metabolic and hormonal profiling of normotensive women with polycystic ovary syndrome with and without biochemical hyperandrogenism.
    Kałużna M; Krauze T; Ziemnicka K; Wachowiak-Ochmańska K; Kaczmarek J; Janicki A; Wykrętowicz A; Ruchała M; Guzik P
    Endocrine; 2021 Jun; 72(3):882-892. PubMed ID: 33619670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.